Skip to main content
Erschienen in: Pediatric Nephrology 12/2015

01.12.2015 | Original Article

Prevalence, predictors, and outcomes of cardiorenal syndrome in children with dilated cardiomyopathy: a report from the Pediatric Cardiomyopathy Registry

verfasst von: Ahmad Kaddourah, Stuart L. Goldstein, Steven E. Lipshultz, James D. Wilkinson, Lynn A. Sleeper, Minmin Lu, Steven D. Colan, Jeffrey A. Towbin, Scott I. Aydin, Joseph Rossano, Melanie D. Everitt, Jeffrey G. Gossett, Paolo Rusconi, Paul F. Kantor, Rakesh K. Singh, John L. Jefferies

Erschienen in: Pediatric Nephrology | Ausgabe 12/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

The association of cardiorenal syndrome (CRS) with mortality in children with dilated cardiomyopathy (DCM) is unknown.

Methods

With a modified Schwartz formula, we estimated glomerular filtration rates (eGFR) for children ≥1 year of age with DCM enrolled in the Pediatric Cardiomyopathy Registry at the time of DCM diagnosis and annually thereafter. CRS was defined as an eGFR of <90 mL/min/1.73 m2. Children with and without CRS were compared on survival and serum creatinine concentrations (SCr). The association between eGFR and echocardiographic measures was assessed with linear mixed-effects regression models.

Results

Of 285 eligible children with DCM diagnosed at ≥1 year of age, 93 were evaluable. CRS was identified in 57 of these 93 children (61.3 %). Mean (standard deviation) eGFR was 62.0 (22.6) mL/min/1.73 m2 for children with CRS and 108.0 (14.0) for those without (P < 0.001); median SCr concentrations were 0.9 and 0.5 mg/dL, respectively (P < 0.001). The mortality hazard ratio of children with CRS versus those with no CRS was 2.4 (95 % confidence interval 0.8–7.4). eGFR was positively correlated with measures of left ventricular function and negatively correlated with age.

Conclusions

CRS in children newly diagnosed with DCM may be associated with higher 5-year mortality. Children with DCM, especially those with impaired left ventricular function, should be monitored for renal disease.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Berl T, Henrich W (2006) Kidney–heart interactions: epidemiology, pathogenesis, and treatment. Clin J Am Soc Nephrol 1:8–18CrossRefPubMed Berl T, Henrich W (2006) Kidney–heart interactions: epidemiology, pathogenesis, and treatment. Clin J Am Soc Nephrol 1:8–18CrossRefPubMed
2.
Zurück zum Zitat Cody RJ, Ljungman S, Covit AB, Kuboi SH, Sealey JE, Pondolfino K, Clark M, James G, Laragh JH (1988) Regulation of glomerular filtration rate in chronic congestive heart failure patients. Kidney Int 34:361–367CrossRefPubMed Cody RJ, Ljungman S, Covit AB, Kuboi SH, Sealey JE, Pondolfino K, Clark M, James G, Laragh JH (1988) Regulation of glomerular filtration rate in chronic congestive heart failure patients. Kidney Int 34:361–367CrossRefPubMed
3.
Zurück zum Zitat Ronco C, Haapio M, House AA, Anavekar N, Bellomo R (2008) Cardiorenal syndrome. J Am Coll Cardiol 52:1527–1539CrossRefPubMed Ronco C, Haapio M, House AA, Anavekar N, Bellomo R (2008) Cardiorenal syndrome. J Am Coll Cardiol 52:1527–1539CrossRefPubMed
4.
Zurück zum Zitat Ronco C, McCullough P, Anker SD, Anand I, Aspromonte N, Bagshaw SM, Bellomo R, Berl T, Bobek I, Cruz DN, Daliento L, Davenport A, Haapio M, Hillege H, House AA, Katz N, Maisel A, Mankad S, Zanco P, Mebazaa A, Palazzuoli A, Ronco F, Shaw A, Sheinfeld G, Soni S, Vescovo G, Zamperetti N, Ponikowski P (2010) Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality Initiative. Eur Heart J 31:703–711PubMedCentralCrossRefPubMed Ronco C, McCullough P, Anker SD, Anand I, Aspromonte N, Bagshaw SM, Bellomo R, Berl T, Bobek I, Cruz DN, Daliento L, Davenport A, Haapio M, Hillege H, House AA, Katz N, Maisel A, Mankad S, Zanco P, Mebazaa A, Palazzuoli A, Ronco F, Shaw A, Sheinfeld G, Soni S, Vescovo G, Zamperetti N, Ponikowski P (2010) Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality Initiative. Eur Heart J 31:703–711PubMedCentralCrossRefPubMed
5.
Zurück zum Zitat Krawczeski CD, Goldstein SL, Woo JG, Wang Y, Piyaphanee N, Ma Q, Bennett M, Devarajan P (2011) Temporal relationship and predictive value of urinary acute kidney injury biomarkers after pediatric cardiopulmonary bypass. J Am Coll Cardiol 58:2301–2309PubMedCentralCrossRefPubMed Krawczeski CD, Goldstein SL, Woo JG, Wang Y, Piyaphanee N, Ma Q, Bennett M, Devarajan P (2011) Temporal relationship and predictive value of urinary acute kidney injury biomarkers after pediatric cardiopulmonary bypass. J Am Coll Cardiol 58:2301–2309PubMedCentralCrossRefPubMed
6.
Zurück zum Zitat Bennett M, Dent CL, Ma Q, Dastrala S, Grenier F, Workman R, Syed H, Ali S, Barasch J, Devarajan P (2008) Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study. Clin J Am Soc Nephrol 3:665–673PubMedCentralCrossRefPubMed Bennett M, Dent CL, Ma Q, Dastrala S, Grenier F, Workman R, Syed H, Ali S, Barasch J, Devarajan P (2008) Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study. Clin J Am Soc Nephrol 3:665–673PubMedCentralCrossRefPubMed
7.
Zurück zum Zitat Jois P, Mebazaa A (2012) Cardio-renal syndrome type 2: epidemiology, pathophysiology, and treatment. Semin Nephrol 32:26–30CrossRefPubMed Jois P, Mebazaa A (2012) Cardio-renal syndrome type 2: epidemiology, pathophysiology, and treatment. Semin Nephrol 32:26–30CrossRefPubMed
8.
Zurück zum Zitat Hillege HL, Nitsch D, Pfeffer MA, Swedberg K, McMurray JJ, Yusuf S, Granger CB, Michelson EL, Ostergren J, Cornel JH, de Zeeuw D, Pocock S, van Veldhuisen DJ (2006) Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 113:671–678CrossRefPubMed Hillege HL, Nitsch D, Pfeffer MA, Swedberg K, McMurray JJ, Yusuf S, Granger CB, Michelson EL, Ostergren J, Cornel JH, de Zeeuw D, Pocock S, van Veldhuisen DJ (2006) Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 113:671–678CrossRefPubMed
9.
Zurück zum Zitat Price JF, Mott AR, Dickerson HA, Jefferies JL, Nelson DP, Chang AC, O’Brian Smith E, Towbin JA, Dreyer WJ, Denfield SW, Goldstein SL (2008) Worsening renal function in children hospitalized with decompensated heart failure: evidence for a pediatric cardiorenal syndrome? Pediatr Crit Care Med 9:279–284CrossRefPubMed Price JF, Mott AR, Dickerson HA, Jefferies JL, Nelson DP, Chang AC, O’Brian Smith E, Towbin JA, Dreyer WJ, Denfield SW, Goldstein SL (2008) Worsening renal function in children hospitalized with decompensated heart failure: evidence for a pediatric cardiorenal syndrome? Pediatr Crit Care Med 9:279–284CrossRefPubMed
10.
Zurück zum Zitat Isakova T, Houston J, Santacruz L, Schiavenato E, Somarriba G, Harmon WG, Lipshultz SE, Miller TL, Rusconi PG (2013) Associations between fibroblast growth factor 23 and cardiac characteristics in pediatric heart failure. Pediatr Nephrol 28:2035–2042PubMedCentralCrossRefPubMed Isakova T, Houston J, Santacruz L, Schiavenato E, Somarriba G, Harmon WG, Lipshultz SE, Miller TL, Rusconi PG (2013) Associations between fibroblast growth factor 23 and cardiac characteristics in pediatric heart failure. Pediatr Nephrol 28:2035–2042PubMedCentralCrossRefPubMed
11.
Zurück zum Zitat Lipshultz SE, Sleeper LA, Towbin JA, Lowe AM, Orav EJ, Cox GF, Lurie PR, McCoy KL, McDonald MA, Messere JE, Colan SD (2003) The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med 348:1647–1655CrossRefPubMed Lipshultz SE, Sleeper LA, Towbin JA, Lowe AM, Orav EJ, Cox GF, Lurie PR, McCoy KL, McDonald MA, Messere JE, Colan SD (2003) The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med 348:1647–1655CrossRefPubMed
12.
Zurück zum Zitat Towbin JA, Lowe AM, Colan SD, Sleeper LA, Orav EJ, Clunie S, Messere J, Cox GF, Lurie PR, Hsu D, Canter C, Wilkinson JD, Lipshultz SE (2006) Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA 296:1867–1876CrossRefPubMed Towbin JA, Lowe AM, Colan SD, Sleeper LA, Orav EJ, Clunie S, Messere J, Cox GF, Lurie PR, Hsu D, Canter C, Wilkinson JD, Lipshultz SE (2006) Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA 296:1867–1876CrossRefPubMed
13.
Zurück zum Zitat Hsu DT, Canter CE (2010) Dilated cardiomyopathy and heart failure in children. Heart Fail Clin 6:415–432CrossRefPubMed Hsu DT, Canter CE (2010) Dilated cardiomyopathy and heart failure in children. Heart Fail Clin 6:415–432CrossRefPubMed
14.
Zurück zum Zitat Hogg RJ, Furth S, Lemley KV, Portman R, Schwartz GJ, Coresh J, Balk E, Lau J, Levin A, Kausz AT, Eknoyan G, Levey AS (2003) National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification. Pediatrics 111:1416–1421CrossRefPubMed Hogg RJ, Furth S, Lemley KV, Portman R, Schwartz GJ, Coresh J, Balk E, Lau J, Levin A, Kausz AT, Eknoyan G, Levey AS (2003) National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification. Pediatrics 111:1416–1421CrossRefPubMed
15.
Zurück zum Zitat Grenier MA, Osganian SK, Cox GF, Towbin JA, Colan SD, Lurie PR, Sleeper LA, Orav EJ, Lipshultz SE (2000) Design and implementation of the North American pediatric cardiomyopathy registry. Am Heart J 139:S86–S95CrossRefPubMed Grenier MA, Osganian SK, Cox GF, Towbin JA, Colan SD, Lurie PR, Sleeper LA, Orav EJ, Lipshultz SE (2000) Design and implementation of the North American pediatric cardiomyopathy registry. Am Heart J 139:S86–S95CrossRefPubMed
16.
Zurück zum Zitat National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39:S1–S266 National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39:S1–S266
17.
Zurück zum Zitat Schwartz GJ, Munoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629–637PubMedCentralCrossRefPubMed Schwartz GJ, Munoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629–637PubMedCentralCrossRefPubMed
18.
Zurück zum Zitat Schwartz GJ, Work DF (2009) Measurement and estimation of GFR in children and adolescents. Clin J Am Soc Nephrol 4:1832–1843CrossRefPubMed Schwartz GJ, Work DF (2009) Measurement and estimation of GFR in children and adolescents. Clin J Am Soc Nephrol 4:1832–1843CrossRefPubMed
19.
Zurück zum Zitat Palatini P, Mormino P, Dorigatti F, Santonastaso M, Mos L, De Toni R, Winnicki M, Dal Follo M, Biasion T, Garavelli G, Pessina AC (2006) Glomerular hyperfiltration predicts the development of microalbuminuria in stage 1 hypertension: The HARVEST. Kidney Int 70:578–584PubMed Palatini P, Mormino P, Dorigatti F, Santonastaso M, Mos L, De Toni R, Winnicki M, Dal Follo M, Biasion T, Garavelli G, Pessina AC (2006) Glomerular hyperfiltration predicts the development of microalbuminuria in stage 1 hypertension: The HARVEST. Kidney Int 70:578–584PubMed
20.
Zurück zum Zitat Pruijm M, Wuerzner G, Maillard M, Bovet P, Renaud C, Bochud M, Burnier M (2010) Glomerular hyperfiltration and increased proximal sodium reabsorption in subjects with type 2 diabetes or impaired fasting glucose in a population of the African region. Nephrol Dial Transplant 25:2225–2231CrossRefPubMed Pruijm M, Wuerzner G, Maillard M, Bovet P, Renaud C, Bochud M, Burnier M (2010) Glomerular hyperfiltration and increased proximal sodium reabsorption in subjects with type 2 diabetes or impaired fasting glucose in a population of the African region. Nephrol Dial Transplant 25:2225–2231CrossRefPubMed
21.
Zurück zum Zitat Sunder-Plassmann G, Horl WH (2004) A critical appraisal for definition of hyperfiltration. Am J Kidney Dis 43:396–397CrossRefPubMed Sunder-Plassmann G, Horl WH (2004) A critical appraisal for definition of hyperfiltration. Am J Kidney Dis 43:396–397CrossRefPubMed
22.
Zurück zum Zitat Cnaan A, Ryan L (1998) Survival analysis in natural history studies of disease. Stat Med 8:1255–1268CrossRef Cnaan A, Ryan L (1998) Survival analysis in natural history studies of disease. Stat Med 8:1255–1268CrossRef
23.
Zurück zum Zitat Chen MC, Chang HW, Cheng CI, Chen YH, Chai HT (2003) Risk stratification of in-hospital mortality in patients hospitalized for chronic congestive heart failure secondary to non-ischemic cardiomyopathy. Cardiology 100:136–142CrossRefPubMed Chen MC, Chang HW, Cheng CI, Chen YH, Chai HT (2003) Risk stratification of in-hospital mortality in patients hospitalized for chronic congestive heart failure secondary to non-ischemic cardiomyopathy. Cardiology 100:136–142CrossRefPubMed
24.
Zurück zum Zitat Jefferies JL, Goldstein SL (2012) Cardiorenal syndrome: an emerging problem in pediatric critical care. Pediatr Nephrol 28:855–862CrossRefPubMed Jefferies JL, Goldstein SL (2012) Cardiorenal syndrome: an emerging problem in pediatric critical care. Pediatr Nephrol 28:855–862CrossRefPubMed
25.
Zurück zum Zitat Blinder JJ, Goldstein SL, Lee VV, Baycroft A, Fraser CD, Nelson D, Jefferies JL (2012) Congenital heart surgery in infants: effects of acute kidney injury on outcomes. J Thorac Cardiovasc Surg 143:368–374CrossRefPubMed Blinder JJ, Goldstein SL, Lee VV, Baycroft A, Fraser CD, Nelson D, Jefferies JL (2012) Congenital heart surgery in infants: effects of acute kidney injury on outcomes. J Thorac Cardiovasc Surg 143:368–374CrossRefPubMed
26.
Zurück zum Zitat Fadrowski JJ, Neu AM, Schwartz GJ, Furth SL (2011) Pediatric GFR estimating equations applied to adolescents in the general population. Clin J Am Soc Nephrol 6:1427–1435PubMedCentralCrossRefPubMed Fadrowski JJ, Neu AM, Schwartz GJ, Furth SL (2011) Pediatric GFR estimating equations applied to adolescents in the general population. Clin J Am Soc Nephrol 6:1427–1435PubMedCentralCrossRefPubMed
27.
Zurück zum Zitat Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffies MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G (2003) National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139:137–147CrossRefPubMed Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffies MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G (2003) National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139:137–147CrossRefPubMed
28.
Zurück zum Zitat Damman K, Masson S, Hillege HL, Maggioni AP, Coors AA, Opasich C, van Veldhuisen DJ, Montagna L, Cosmi F, Tognoni G, Tavazzi L, Latini R (2011) Clinical outcome of renal tubular damage in chronic heart failure. Eur Heart J 32:2705–2712CrossRefPubMed Damman K, Masson S, Hillege HL, Maggioni AP, Coors AA, Opasich C, van Veldhuisen DJ, Montagna L, Cosmi F, Tognoni G, Tavazzi L, Latini R (2011) Clinical outcome of renal tubular damage in chronic heart failure. Eur Heart J 32:2705–2712CrossRefPubMed
29.
Zurück zum Zitat Hebert K, Dias A, Delgado MC, Franco E, Tamariz L, Steen D, Trahan P, Major B, Arcement L (2010) Epidemiology and survival of the five stages of chronic kidney disease in a systolic heart failure population. Eur J Heart Fail 12:861–865CrossRefPubMed Hebert K, Dias A, Delgado MC, Franco E, Tamariz L, Steen D, Trahan P, Major B, Arcement L (2010) Epidemiology and survival of the five stages of chronic kidney disease in a systolic heart failure population. Eur J Heart Fail 12:861–865CrossRefPubMed
30.
Zurück zum Zitat de Silva R, Nikitin NP, Witte KK, Rigby AS, Goode K, Bhandari S, Clark AL, Cleland JG (2006) Incidence of renal dysfunction over 6 months in patients with chronic heart failure due to left ventricular systolic dysfunction: contributing factors and relationship to prognosis. Eur Heart J 27:569–581CrossRefPubMed de Silva R, Nikitin NP, Witte KK, Rigby AS, Goode K, Bhandari S, Clark AL, Cleland JG (2006) Incidence of renal dysfunction over 6 months in patients with chronic heart failure due to left ventricular systolic dysfunction: contributing factors and relationship to prognosis. Eur Heart J 27:569–581CrossRefPubMed
31.
Zurück zum Zitat Oyedeji AT, Balogun MO, Akintomide AA, Adebayo RA, Ajayi OE, Ogunyemi S, Ajayi EA (2011) The significance of mild renal dysfunction in chronic heart failure. West Afr J Med 30:442–446PubMed Oyedeji AT, Balogun MO, Akintomide AA, Adebayo RA, Ajayi OE, Ogunyemi S, Ajayi EA (2011) The significance of mild renal dysfunction in chronic heart failure. West Afr J Med 30:442–446PubMed
32.
Zurück zum Zitat Bhatia RS, Tu JV, Lee DS, Austin PC, Fang J, Haouzi A, Gong Y, Liu PP (2006) Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 355:260–269CrossRefPubMed Bhatia RS, Tu JV, Lee DS, Austin PC, Fang J, Haouzi A, Gong Y, Liu PP (2006) Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 355:260–269CrossRefPubMed
33.
Zurück zum Zitat Jungbauer CG, Birner C, Jung B, Buchner S, Lubnow M, von Bary C, Eldemann D, Banas B, Mack M, Boger CA, Riegger G, Luchner A (2011) Kidney injury molecule-1 and N-acetyl-beta-D-glucosaminidase in chronic heart failure: possible biomarkers of cardiorenal syndrome. Eur J Heart Fail 13:1104–1110CrossRefPubMed Jungbauer CG, Birner C, Jung B, Buchner S, Lubnow M, von Bary C, Eldemann D, Banas B, Mack M, Boger CA, Riegger G, Luchner A (2011) Kidney injury molecule-1 and N-acetyl-beta-D-glucosaminidase in chronic heart failure: possible biomarkers of cardiorenal syndrome. Eur J Heart Fail 13:1104–1110CrossRefPubMed
34.
Zurück zum Zitat Finney H, Newman DJ, Thakkar H, Fell JM, Price CP (2000) Reference ranges for plasma cystatin C and creatinine measurements in premature infants, neonates, and older children. ArcH Dis Child 82:71–75PubMedCentralCrossRefPubMed Finney H, Newman DJ, Thakkar H, Fell JM, Price CP (2000) Reference ranges for plasma cystatin C and creatinine measurements in premature infants, neonates, and older children. ArcH Dis Child 82:71–75PubMedCentralCrossRefPubMed
36.
Zurück zum Zitat Nohria A, Hassleblad V, Stebbins A, Pauly DF, Fonarow GC, Shah M, Yancy CW, Califf RM, Stevenson LW, Hill JA (2008) Cardiorenal interactions: insights from the ESCAPE trial. J Am Coll Cardiol 13:1268–1274CrossRef Nohria A, Hassleblad V, Stebbins A, Pauly DF, Fonarow GC, Shah M, Yancy CW, Califf RM, Stevenson LW, Hill JA (2008) Cardiorenal interactions: insights from the ESCAPE trial. J Am Coll Cardiol 13:1268–1274CrossRef
37.
Zurück zum Zitat Bongartz LG, Braam B, Gaillard CA, Cramer MJ, Goldschmeding R, Verhaar MC, Doevendans PA, Joles JA (2012) Target organ cross talk in cardiorenal syndrome: animal models. Am J Physiol Renal Physiol 303:F1253–F1263CrossRefPubMed Bongartz LG, Braam B, Gaillard CA, Cramer MJ, Goldschmeding R, Verhaar MC, Doevendans PA, Joles JA (2012) Target organ cross talk in cardiorenal syndrome: animal models. Am J Physiol Renal Physiol 303:F1253–F1263CrossRefPubMed
38.
Zurück zum Zitat Cruz DN, Schmidt-Ott KM, Vescovo G, House AA, Kellum A, Ronco C, McCullough PA (2013) Pathophysiology of cardiorenal syndrome type 2 in stable chronic heart failure: workgroup statements from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol 182:117–136CrossRefPubMed Cruz DN, Schmidt-Ott KM, Vescovo G, House AA, Kellum A, Ronco C, McCullough PA (2013) Pathophysiology of cardiorenal syndrome type 2 in stable chronic heart failure: workgroup statements from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol 182:117–136CrossRefPubMed
39.
Zurück zum Zitat López-Sendón J, Swedberg K, McMurray J, Tamargo J, Maggioni AP, Dargie H, Tendera M, Waagstein F, Kjekshus J, Lechat P, Torp-Pedersen C (2004) Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. The Task Force on ACE-inhibitors of the European Society of Cardiology. Eur Heart J 25:1454–1470CrossRefPubMed López-Sendón J, Swedberg K, McMurray J, Tamargo J, Maggioni AP, Dargie H, Tendera M, Waagstein F, Kjekshus J, Lechat P, Torp-Pedersen C (2004) Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. The Task Force on ACE-inhibitors of the European Society of Cardiology. Eur Heart J 25:1454–1470CrossRefPubMed
40.
Zurück zum Zitat Filler G, Lipshultz SE (2012) Why multidisciplinary clinics should be the standard for treating chronic kidney disease. Pediatr Nephrol 27:1831–1834CrossRefPubMed Filler G, Lipshultz SE (2012) Why multidisciplinary clinics should be the standard for treating chronic kidney disease. Pediatr Nephrol 27:1831–1834CrossRefPubMed
Metadaten
Titel
Prevalence, predictors, and outcomes of cardiorenal syndrome in children with dilated cardiomyopathy: a report from the Pediatric Cardiomyopathy Registry
verfasst von
Ahmad Kaddourah
Stuart L. Goldstein
Steven E. Lipshultz
James D. Wilkinson
Lynn A. Sleeper
Minmin Lu
Steven D. Colan
Jeffrey A. Towbin
Scott I. Aydin
Joseph Rossano
Melanie D. Everitt
Jeffrey G. Gossett
Paolo Rusconi
Paul F. Kantor
Rakesh K. Singh
John L. Jefferies
Publikationsdatum
01.12.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Nephrology / Ausgabe 12/2015
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-015-3165-8

Weitere Artikel der Ausgabe 12/2015

Pediatric Nephrology 12/2015 Zur Ausgabe

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.